Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Honestly, I don't even know. It has been so difficult to differentiate fantasy from reality in the past forward looking statements that I feel like there is no solid basis to predict what success might look like.
I'll stick with "an uptick in revs, continued investment in next gen opportunities, and an honest appraisal/review of prior predictions".
That said, a much better measure of success would be "whatever is necessary to persuade new investors to pull the trigger".
$SHMN: Nostalgia Anyone? Probably TOP TEN of AHole Barron's lies👇️
I specifically like the "Stay away from misinformation"...
As previous stated acquisition is on track, both companies have signed definitive agreement. The company will share the details at appropriate time in near future. The Company's operation is in line with its outlook & growth strategy. Stay away from misinformation $SHMN #SOHMINC
— SOHM, Inc. (@sohminc) November 4, 2021
so I guess you don't think maybe this was the reason for the pathetic 4th qtr, the lowest rev's posted in a qtr in how long ?
imo you are half right, just lagging behind because that fits your agenda here..
1.2 to 1.5 million in revs? With what products???? Remember when they had "container loads" of product going out and only showed about 30k for it?
Prepare to be severely disappointed?
$SHMN: MPStock: To take a Reasonable attempt to answer this....
One would need to Step back to Jan-Feb '24 time frame. And reference👇️ this 'X'
Subject: Exciting News – CDMO Orders for Skincare Products to the Dominican Republic!
— SOHM, Inc. (@sohminc) February 8, 2024
Dear Stakeholders,
We are thrilled to announce that yesterday, we received significant CDMO (Contract Development and Manufacturing Organization) orders for the export of two of our premium…
We are pleased to share some photos of our Carlsbad plant with our valued customers who have requested them. Our operations are running smoothly and we are very satisfied with the results. We anticipate a strong performance in the first quarter. Thank you for your continued… pic.twitter.com/oszy1uBCIB
— SOHM, Inc. (@sohminc) February 5, 2024
So what’s considered a strong Q1 in everyone’s opinion?
500k. 1 million. 1.5 million
IMHO, we're still at the point where the impact of revenue greatly outweighs profits. Hell, I was actually happy to see that spending more than offset the meager revenues, and frankly I'd rather see a further decline in net earnings if it was in the context of radically increased revenue and a substantial uptick in infrastructure investment/COGS. One of the biggest issues with SHMN for as long as I've been involved is a lack of actual sales. Infrastructure spending is often a short term investment (hence many microcap companies touting their EBITDA/Adjusted EBIDTA rather than earnings), and COGS tends to decline with experience. Actually demonstrating that you can generate revenue is priceless.
I have zero information to base an opinion on what the numbers might look like, but past performance makes me at least a bit skeptical...it seems that each quarter we have wonderful outlook followed by meh, so I remain firmly in Missouri right now...Show Me.
Given the lack of volume despite numerous cheery announcements, I can only imagine that the broader investment community feels much the same.
4Q last year ($19,025) would certainly be disappointing. I'm taking them at their word, a "strong" 1Q.
...based on the Tweets in my last post.
We'll see in a few days.
hL shmn
I don't see anything that happened last quarter that would make me believe that the revenue would be much different than Q4 of last year. If anything, i'd assume the net income could be less if they are spending more now on personnel and setting up facilities.
Good question, I have a figure in mind, how about your estimate?
We are pleased to share some photos of our Carlsbad plant with our valued customers who have requested them. Our operations are running smoothly and we are very satisfied with the results. We anticipate a strong performance in the first quarter. Thank you for your continued… pic.twitter.com/oszy1uBCIB
— SOHM, Inc. (@sohminc) February 5, 2024
Subject: Exciting News – CDMO Orders for Skincare Products to the Dominican Republic!
— SOHM, Inc. (@sohminc) February 8, 2024
Dear Stakeholders,
We are thrilled to announce that yesterday, we received significant CDMO (Contract Development and Manufacturing Organization) orders for the export of two of our premium…
We are pleased to announce that we have a new stock of Levetiracetam, a medication used to treat various types of seizures in epilepsy. Levetiracetam is available in different formulations, such as tablets, liquid, and injection. It is a generic drug that is also sold under the… pic.twitter.com/5RigMTX4OZ
— SOHM, Inc. (@sohminc) February 8, 2024
What would be seen as "a good one" revenue wise this quarter?
1Q 2023 was $52,000, they filed it on May 11, 2023:
https://www.otcmarkets.com/otcapi/company/financial-report/369721/content
___
If they are going to get to "a few million" in Revs this year, this 1Q needs to be a good one. Then ramp up as the year progresses.
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Announces-Business-Outlook-for-2024?id=423706
Baron and Dr. David...let's hear about the orders, and the San Diego facility. Thx. hL shmn
Eddie Chung (Coastar) at Bio 2024 on June 2, 2024:
Cell and Gene Therapy and Genome Editing
https://convention.bio.org/sessions/coastar-therapeutics-inc-1?&filters.type=CP&filters.TYPE=CP&searchgroup=libraryentry-sessions
https://www.linkedin.com/in/chungeddie/recent-activity/all/
Also at: https://bcic.bio.org/program/company-presentations?sp_sn=linkedin&spclid=FFC3D955-7493-42EA-AD70-6AC676F523B8
___
hL shmn
Ask and you shall receive. SHMN just tweeted exactly what you described.
“Red blood cell carriers revolutionize genome editing”#SOHMInc #redbloodcell #revolutionize #Genomediting #medicalreserach #SOHM #PharmacyTrends #MedicineTrends #Infographic #coastartherapeutics #cas9 #crispr #geneediting#Genomeadvantages $SHMN pic.twitter.com/hLHaqCCGZO
— SOHM, Inc. (@sohminc) May 9, 2024
Getting some volume today
$SHMN: Wondering when the next ChatGPT lesson on Gene-Editing will be tweeted...
Anytime in the next '2' hours.
It's Soooooo....Exciting!
'F'kng Ahole Barron get your rear end moving & tweet about REVENUE & POs. especially about ABBIE
And WTF are your sales & mktg team doing? Oh wait...they're all Molecular biology experts🤔 They don't have time to sell Rx.
Are you planning to PR on 05/15...Talking about how great the EOY '24 will be?
And then PUNT to 2025?
Or are you FINALLY going to show TANGIBLE PROGRESS, the kind that moves the PPS UPWARDS?
We'll get a peek behind the curtain next week when the Q1 financials hit.
$SHMN: MPStock: The "Science Advisor"...Mark Stevens...decided to get INVESTED here
He bought a few SHS 😂
Put your $ where your mouth is M-Fkers! [Everybody except Dr. Bhat]
$SHMN: HL: Definitely they [CoStar + SoHM] have an Investment from
some deep pockets [Bio-Tech PubCo?]
Don't read too much into this.....
I noticed that the V.C. who comes up as part of the company [CoStar] : Haolin Sung from Taiwan, is also funding BioEclipse Therapeutics.
I personally know someone from BioEclipse [Startup Co]
Both could be bagging some POs from a PubCo.Illumina [$ILMN] comes up on pubs & Recent Research on mRNA delivery using Red-Blood Cell Membranes, as CoStar is currently doing.
I think $SHMN is close to putting out a PR. Let's see......
I posted your link to the Biospace article on X
This MOU with Coastar is heating up imo:
This is the 3rd time they have Tweeted about it, and referenced the PR.
Discover the power within: From editing genes to enhancing delivery, discover how red blood cells are revolutionizing medicine.
— SOHM, Inc. (@sohminc) May 1, 2024
Click through to the press release:https://t.co/xsAsgwgizY#GeneEditing #RedBloodCells #MedicalInnovation $SHMN#biotech #cancerresearch #invivo… pic.twitter.com/mUUnJxgiaf
Put down your highlighter, and go look at his resume on LinkedIn....Then tell me if you're impressed with the guy. The fact that he's here and Tweeting anything related to $shmn is a good thing, imo.
Unless you'd like to post your personal Twitter profile here, and your LinkedIn resume showing your stellar scientific credentials? I know you won't, but then again, I won't either. :)
hL. Shmn
Guess who replied to this Tweet?
— Mark S (@DrMarkScience) April 30, 2024
Did you know red blood cell membranes can be used to deliver gene editing tools safely into our cells? This innovative approach could revolutionize treatments for genetic disorders! #GenomeEditing #HealthInnovation $SHMN pic.twitter.com/GsFk6IyNQX
— SOHM, Inc. (@sohminc) April 30, 2024
What kind of numbers are expected in the Q1 financials? I can't imagine it will be anything much from the ordinary low numbers.
I would think those would wait until at least Thursday to throw in the towel, but who knows....
I am anxious to see Q1 also, especially after they already hinted it would be good.....
Looks more like impatient traders to me. Selling to break even and send their money elsewhere. Maybe they can't see the bids at .0011... the 1Q is coming in 2 weeks, even if there's no news to pacify them.
In Aguilars recent interview, he hinted at 'more info to come.' Who knows what it will be, but I'm banking on this being a good start to 2024 for them.
HL. SHMN
Good luck hl !
SHMN still bleeding out......strange to see selling like this on a Monday, almost as if someone knows there's no news coming....
Yup and 2 weeks to the 1Q 2024. :)
HL. Shmn. Baby pharma at .0012. :)
Got me a couple of those today. :)
right down to the wire, due today.....
Attorney Letter with Respect to Current Information: https://www.otcmarkets.com/otcapi/company/financial-report/399370/content
The company has published, the Attorney Letter with Respect to Current Information.https://t.co/awlhs6KCI3 $SHMN
— SOHM, Inc. (@sohminc) April 28, 2024
Cliff notes for today's tweet: They are excited.
TWEET
AACR Summary:
— SOHM, Inc. (@sohminc) April 22, 2024
We are thrilled to report that our presentation at the #AACR Annual Meeting garnered positive feedback from attendees, including esteemed research scholars and scientists. A summary of our internal discussions is enclosed for your review. Stay tuned for further… pic.twitter.com/jRaH6h9PRC
You too hl, lots of time is right !
Cheers !
Good weekend all, Gin n tonics. (lots of lime) :)
do you know what truth even means ?
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173779054&txt2find=red%20flag
$SHMN:HL: I'd like to see these👇️guys '1' thro' '3' OWN some SHS!
***I have a feeling that the company is setting up a base for real investor interest in $SHMN
via some very REAL Business dealings with Companies [Incl Japanese Co's]
Surely after all this time it's NOT the same Old B.S. tweets?
I've talked about Dr. Bhatt in many of my posts earlier this year. He's well known & respected.
And apparently, he put his $ where his EXPERTISE is!
Why would they pass up an Opportunity like this?
Also:- S/Hs want to see what Barron's Stake is in $SHMN?
1. Mark Stevens, Science Advisor:
2. Eddie Chung, Coastar CEO:
3. Eric Furman, Ph.D. Knobbe Martens Sohm Intellectual Property Attorney:
4. Dr. Krishna Bhatt, Chief Medical Advisor, Bioscientist and Cardiologist:
Current owner of 82 Million Common shares, and recent Preferred Shares in exchange for Funding.
These are the Professionals at the $SHMN helm:
In no particular order...They can bring it home, imo.
Mark Stevens, Science Advisor:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174197635
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174136261
https://www.linkedin.com/in/mark-stevens-phd-810167a/
Eddie Chung, Coastar CEO:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174150084
"This marks a thrilling juncture for both companies and the realm of gene editing," stated Eddie Chung, CEO of Coastar. "We're intrigued by the precision and integrase capabilities presented by the ABBIE system. This partnership will yield a novel platform applicable in both laboratory and clinical use."
https://coastartherapeutics.com/about-us/
https://www.globenewswire.com/news-release/2024/04/01/2855240/0/en/SOHM-Inc-and-Coastar-Therapeutics-Sign-MoU-and-Announce-Collaboration-to-Revolutionize-Genome-Editing-Using-Red-Blood-Cell-Membrane-Derived-Carriers.html
Tony Tontat, Strategic Financial Analyst:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173733984
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173582848
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173546689
Alfred Gallegos, SHMN Research Scientist:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173660637
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173660026
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173659156
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Collaborates-with-University-of-Arizona-Center-for-Innovation-to-Advance-ABBIE-a-Groundbreaking-Non-Viral-Gene-Edit?id=416912
Eric Furman, Ph.D. Knobbe Martens Sohm Intellectual Property Attorney:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173289185
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173246026
Wm. Dewey Rushing, VP of Quality Sohm:
https://www.linkedin.com/in/wm-dewey-rushing-7505a95/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173082914
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173082680
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=173031688
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172828177
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172794328
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-as-VP-of-Quality-with-Immediate-Effect?id=413696
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announces-the-Appointment-of-Wm-Dewey-Rushing-former-US-FDA-Investigator-to-its-Advisory-Board?id=344969
Dr. Krishna Bhatt, Chief Medical Advisor, Bioscientist and Cardiologist:
Current owner of 82 Million Common shares, and recent Preferred Shares in exchange for Funding.
https://www.otcmarkets.com/otcapi/company/financial-report/396087/content
https://www.biomedwire.com/leadership-changes-at-sohm-inc-shmn-to-strengthen-growth-strategies-for-generic-drug-market-and-gene-editing-platform-development/
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Expands-Its-Advisory-Board-Appointing-Dr-Krishna-Bhat-MD-PhD-FACC-as-Chief-Medical-Advisor?id=411792
Dr. David Aguilar, Sohm Chief Operating Officer:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172703663
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172599661
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Announce-the-Appointment-of-Dr-David-Aguilar-PhD-as-a-Chief-Operating-Officer-with-the-Company-with-Immediate-E?id=410079
https://www.otcmarkets.com/stock/SHMN/news/SOHM-Inc-Expands-Advisory-Board-with-Appointment-of-Dr-David-Aguilar-PhD-as-its-Expert-Medical-Advisor?id=346149
We’re thrilled to announce that our presentation at #AACR was met with an exceptional reception. It was an honor to showcase our technology to esteemed researchers and leaders in the biotech industry.
— SOHM, Inc. (@sohminc) April 9, 2024
The overwhelming interest and impact generated by our innovation have been… pic.twitter.com/50Ggv6hqPj
Join COO David Aguilar Ph.D., Research Scientist Alfred Gallegos, and Science Advisor Mark Stevens at #AARC2024 to discover our groundbreaking gene-editing platform that will revolutionize how we treat Colon Cancer.
— SOHM, Inc. (@sohminc) March 28, 2024
More: https://t.co/tcmjjGEEW1#SOHMInc #ABBIE $SHMN pic.twitter.com/RzYwx8X4yy
After a successful visit to Japan, our COO, Dr. David Aguilar is back and here are couple pictures of him working at Carlsbad facility with production in-charge.
— SOHM, Inc. (@sohminc) January 25, 2024
Secondly, we are glad to share that we are working with multiple companies for CDMO services and production at the… pic.twitter.com/Wj5qUGgpRe
We are happy where things are today with the Year-end FDA approval of our Carlsbad manufacturing facility which will set our company up for a bright 2024 outlook.$SHMN pic.twitter.com/tehLBtiVNs
— SOHM, Inc. (@sohminc) December 31, 2023
Well, the big difference is that stock is on the NASDAQ exchange and SHMN is an alternative reporting Pink Stock on the OTC.
Truth hurts.... cry a little more
4.63 billion market cap. $5.34 loss per share. $20 BV. Zero revenues. Impressive
https://finviz.com/quote.ashx?t=MDGL&p=d
SHMN needs to take lessons from them on how to pump up their stock cuz what they're doing isn't working.
I believe that is incorrect ". But unless it produces income, there will be no pps increase."
Notice the revenue and the stock price
https://www.otcmarkets.com/filing/html?id=17031890&guid=m4Q-ka3VoTeHJth
All on anticipation
Unfortunately, I think you're right, I just don't get these guys. The thing about abbie is that they can milk the hell out if it with tweets. But unless it produces income, there will be no pps increase. Penny stocks tend to run on mostly BS prs. Like acquisition, and such.
Or huge POs and sohm is making products that are already being made and are produced by reputable companies who are already established with distributors.
Followers
|
483
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
65893
|
Created
|
06/10/09
|
Type
|
Free
|
Moderators Myth MDPennyPlayer |
Website: http://www.sohm.com
TWITTER FEED: https://twitter.com/sohminc?lang=en
FACEBOOK FEED: https://www.facebook.com/sohminc/
PRESS RELEASES (SOHM Website): https://www.sohm.com/category/press-releases/
NVSOS: http://nvsos.gov/SOSEntitySearch/CorpDetails.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&nt7=0
NVSOS ACTIONS/AMENDMENTS: http://nvsos.gov/SOSEntitySearch/corpActions.aspx?lx8nvq=DraWvY7hzMLlBgmKhjdRSQ%253d%253d&CorpName=SOHM%2c+INC.
Contact info.
Phone: (714) 522-6700
Address:
4195 Chino Hills Pkway
Ste 675
Chino Hills, CA 91709
Email: info@sohm.com
SHMN RECENT NEWS
SOHM Announces Its Acquisition of ABBIE, a World-Class Gene-Editing Platform Which Can Deliver Genetic Payloads Using Non-Viral Vectors
https://www.globenewswire.com/news-release/2023/09/26/2749662/0/en/SOHM-Announces-Its-Acquisition-of-ABBIE-a-World-Class-Gene-Editing-Platform-Which-Can-Deliver-Genetic-Payloads-Using-Non-Viral-Vectors.html
SOHM Collaborates with University of Arizona Center for Innovation to Advance ABBIE, a Groundbreaking Non-Viral Gene-Editing Technology
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |